10-K Decoder · All companies

Agios Pharmaceuticals, Inc.

AGIO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$54.0M$36.5M+48.0%
Operating income−$472M−$426M−10.9%
Net income−$413M$674M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$55.4M$12.9M+329%
Operating income−$77.2M−$117M+34.0%
Net income−$65.0M−$103M+37.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Agios Pharmaceuticals's revenue in FY2025?
$54.0M in FY2025 (Fiscal year ended Dec 31, 2025), +48.0% vs $36.5M a year earlier, per its 10-K filed Feb 2026.
Was Agios Pharmaceuticals profitable in FY2025?
No: net income was −$413M and operating income −$472M in FY2025.
What was Agios Pharmaceuticals's revenue in Q3 2026?
$55.4M (+329% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.